60 Degrees Pharmaceuticals, Inc. (SXTP)
1.87
+0.12
(+6.86%)
USD |
NASDAQ |
Apr 01, 16:00
1.86
-0.01
(-0.53%)
After-Hours: 04:31
60 Degrees Pharmaceuticals EPS Diluted (Quarterly) : -1.348 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Greenwich LifeSciences, Inc. | -0.3044 |
| Abbott Laboratories | 1.030 |
| GoodRx Holdings, Inc. | 0.0159 |
| Moderna, Inc. | -2.107 |
| BioVie, Inc. | -0.7663 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.440M |
| Revenue (Quarterly) | 0.3164M |
| Total Expenses (Quarterly) | 1.756M |
| Enterprise Value | 11.51M |
| Gross Profit Margin (Quarterly) | 61.85% |
| Profit Margin (Quarterly) | -455.3% |
| Earnings Yield | -565.5% |
| Normalized Earnings Yield | -564.10 |